LLASHNEWSMedical aesthetics media & sourcingRequest Quote
Company NewsAesthetic DevicesSkincare OEM

【South Korea 】Dasan AT Builds K-Beauty Production Hub in Gumi National Industrial Complex with KRW 12 Billion Investment

Source image preserved for article context.
Editor's note

This expansion, sourced from Dasan AT's completion ceremony and Gumi City officials, signals enhanced production scale for OEM/ODM buyers of RF microneedles. The KRW 12 billion investment and 60 new hires may improve supply reliability, but regulatory compliance for medical devices in target markets remains a key question for distributors.

South Korean microneedle manufacturer Dasan AT has completed a new production facility in the Gumi National Industrial Complex, investing KRW 12 billion (approx. USD 9 million) to expand its medical and beauty device manufacturing capacity. The move signals growing supply-chain demand for precision components in the global aesthetic device market, particularly for RF microneedles used in skin rejuvenation and hair restoration procedures. Overseas buyers and distributors should note the company's enhanced production scale and planned hiring of 60 new staff, which may improve lead times and supply reliability for OEM/ODM partners.

Facility expansion and investment

Dasan AT held a completion ceremony on March 30 for its new plant in the Gumi 5 National Industrial Complex, following a 2025 investment agreement with Gumi City. The company invested a total of KRW 12 billion to build the facility, which focuses on expanding medical device manufacturing lines and upgrading advanced production equipment. The expansion is designed to meet growing global demand for aesthetic and dermatological procedures, as well as the rising popularity of K-Beauty products.

Core product and technology

Founded in 1998 as Dasan Precision, the company initially produced industrial components for semiconductors before pivoting to medical device parts. In 2008, it developed medical-grade microneedles and has since specialized in precision components such as RF microneedles for radiofrequency devices and hair transplant needles. Its flagship product, RF microneedles, delivers high-frequency energy to the skin to stimulate collagen production, a key technology in skin tightening, pore refinement, and other aesthetic treatments.

Market and regional impact

The new plant is expected to help diversify Gumi National Industrial Complex's industrial base, which has traditionally been dominated by semiconductor and electronics manufacturing. By adding medical and beauty convergence industries, the region aims to foster future growth sectors and create quality jobs. Gumi City Acting Mayor Jeong Seong-hyun commented: "Dasan AT's completion is a meaningful example of a local company taking a new leap based on advanced technology. It will strengthen the competitiveness of the medical and beauty industry, revitalize the local economy, and create quality jobs."

Sourcing context

For overseas importers and distributors of aesthetic devices, Dasan AT's expanded capacity means potentially shorter lead times and greater production flexibility for OEM orders of RF microneedles and other precision components. The company's long track record in semiconductor-grade manufacturing suggests high quality control standards. Buyers evaluating suppliers for microneedle-based devices—such as fractional RF systems or microneedling pens—may find Dasan AT a reliable partner for core consumables.

Source: Read the original report | Published: May 31, 2026